Stockholders' Equity (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended	12 Months Ended
	Jan. 07, 2019	Jul. 31, 2019	May 31, 2019	Jul. 31, 2019	Jul. 31, 2019	Jul. 31, 2018	Dec. 01, 2018	Nov. 30, 2018	Oct. 26, 2018	Mar. 27, 2017	Feb. 09, 2017	Jan. 18, 2017
Common stock issued		62,290,940		62,290,940	62,290,940	22,430,121			4,830,000		2,179,989	1,117,011
Acquisition in HDS												51.00%
Shares of common stock, obligated to issue												4,830,000
Common stock payable, Shares					1,238,517
Common stock payable, Amount					$ 1,123,188
Net (loss) attributable to noncontrolling interests					(1,665,387)	$ (385,400)
Investment in subsidiary by noncontrolling interest					0	327,593
Non-controlling interest	$ (9,870,762)	$ 16,974,439		$ 16,974,439	16,974,439	$ (5,576,272)
Common stock issued for conversion debt, Shares		1,920,376
Common stock issued for conversion debt, Value		$ 4,350,571			18,406,684
Stock issued for conversion of note payable, Shares				30,000
Stock issued for conversion of note payable, Value				$ 53,000
Fair value		$ 69,000		$ 69,000	$ 69,000
Remain To Be Issued
Common stock issued		588,658		588,658	588,658	302,614
Series H Convertible Preferred Stock
Common stock issued upon conversion of preferred stock		25,200,000		25,200,000	25,200,000
Convertible preferred stock, shares authorized		109,000		109,000	109,000	109,000
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001	$ 0.001	$ 0.001
Convertible preferred stock, shares issued		0		0	0	63,000				63,000
Convertible preferred stock shares issued value		$ 0		$ 0	$ 0	$ 3				$ 3,000,000
Series I Convertible Preferred Stock
Convertible preferred stock, shares authorized		6,000		6,000	6,000	6,000
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001	$ 0.001	$ 0.001
Convertible preferred stock, shares issued		0		0	0	16,590
Convertible preferred stock shares issued value		$ 0		$ 0	$ 0	$ 1
Olaregen Series A Preferred Stock [Member]
Convertible preferred stock, shares authorized		592,683		592,683	592,683	0
Convertible preferred stock, par value (in dollars per share)		$ 0.001		$ 0.001	$ 0.001	$ 0.001
Convertible preferred stock, shares issued		592,683		592,683	592,683	0
Convertible preferred stock shares issued value
Regentys Series A Redeemable Convertible Preferred Stock [Member]
Convertible preferred stock, shares authorized		2,793,192		2,793,192	2,793,192	2,793,192
Convertible preferred stock, par value (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001
Convertible preferred stock shares issued value
NGDx
Non-controlling interest		$ 5,576,272		$ 5,576,272	5,576,272	$ 0
Hema Diagnostic Systems, LLC
Net (loss) attributable to noncontrolling interests					(122,692)
Investment in subsidiary by noncontrolling interest					$ 133,679
B-H Sanford, LLC
Common stock issued upon conversion of preferred stock							25,200,000
Salvo
Common stock issued upon conversion of preferred stock								3,354,645
Moscato
Common stock issued upon conversion of preferred stock								3,276,000
Olaregen
LOI Terms	Pursuant to the Company’s acquisition of Olaregen on January 7, 2019 to acquire a 51% interest, the Company was issued 3,282,632 shares of Olaregen common stock. As of July 31, 2019, Olaregen had a total of 5,648,819 shares of common stock and 592,683 Series A voting preferred stock for a total of 6,241,502 total voting shares outstanding. As such, there are 2,958,870 of shares that belong to non-controlling interest shareholders which represents a 47.41% non-controlling interest.
Regentys
LOI Terms	Pursuant to the Company’s acquisition of Regentys on January 7, 2019 to acquire a 51% interest, the Company was issued 12,048,161 shares of Regentys common stock. As of july 31, 2019, Regentys had a total of 18,623,278 shares of common stock and 2,793,192 Series A voting preferred stock for a total of 21,416,470 total voting shares outstanding. As such, there are 9,368,309 of shares that belong to non-controlling interest shareholders which represents a 43.74% non-controlling interest.
Post Reverse Stock Split
Common stock issued												4,830,000
Net Purchase Price
Common stock issued												5,947,431
After Closing
Common stock issued												420
At Closing
Common stock issued												1,117,011
Stock Purchase Agreement | Olaregen
Common stock issued for acquisition			4,000,000
Notes payable for acquisition			$ 2,000,000
Number of Preferred Stock			592,682